Case report: Dupilumab treatment improved type 2 disorders in a patient with IPEX syndrome diagnosis

We described a case of IPEX syndrome successfully controlled with dupilumab, an anti-IL4 receptor alpha subunit inhibitor. IPEX syndrome is a rare and generally fatal genetic disorder characterized by immune dysregulation, polyendocrinopathy and enteropathy, mostly diagnosed in early childhood. None...

Descripción completa

Detalles Bibliográficos
Autores principales: Caruso, C., Laterza, L., Settanni, C. R., Colantuono, S., Di Mario, C., Tolusso, B., Castrì, F., Gremese, E., Scaldaferri, F., Armuzzi, A., De Simone, C., Peris, K., Chiricozzi, A., Gasbarrini, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875030/
https://www.ncbi.nlm.nih.gov/pubmed/36713411
http://dx.doi.org/10.3389/fimmu.2022.995304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875030/
https://www.ncbi.nlm.nih.gov/pubmed/36713411
http://dx.doi.org/10.3389/fimmu.2022.995304

Ejemplares similares